Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Make a matched gift and support Jewish journalism. DONATE NOW
Israel News

The Oprah Effect Strikes Again

The so-called Oprah Effect has worked its magic on a beauty company based in Tel Aviv.

Stock prices jumped more than 63% for the Israeli company UltraShape after the publication of a favorable article on Oprah.com, according to the Israeli business newspaper Calcalist. Stock in UltraShape gained 26 million shekels (roughly $7 million) in value following the April 19 article, which listed the company’s “body contouring” technology among potential beauty breakthroughs of the coming decade. “It sounds too good to be true, but it may soon be a reality,” said the article, which also appears in the May edition of O, The Oprah Magazine.

The positive attention on Oprah’s website gave a quick and forceful boost to UltraShape, whose “aesthetic medicine” procedure is available in 57 countries, according to the firm’s Web site. The company uses ultrasound technology to “selectively break down fat cells” and create slimmer, more attractive bodies, and is touted in the Oprah.com article as a “relatively painless” alternative to liposuction. The article includes a “big caveat,” however, noting that the technique is designed to eliminate “localized fat” rather than “large volumes,” and adding that UltraShape has not yet been approved for use in the United States.

Though its long-term fortunes remain to be seen, UltraShape would be far from the first company to benefit from a plug by Oprah Winfrey. In addition to her televised book club, which made automatic best-sellers of numerous selections, a mention by the talk show host has dramatically lifted the sales of products ranging from soaps to Spanx to a certain brand of high-end cakes.

This is a moment of great uncertainty. Here’s what you can do about it.

We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news. All donations are still being matched by the Forward Board - up to $100,000 until April 24.

This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.

With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give is invested in the future of the Forward — and telling the American Jewish story fully and fairly.

The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.

Support our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:

  • Credit the Forward
  • Retain our pixel
  • Preserve our canonical link in Google search
  • Add a noindex tag in Google search

See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.